This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Cystic Adenomatoid Malformation Of Lung, Congenital
Information about Cystic Adenomatoid Malformation Of Lung, Congenital: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Cystic Adenomatoid Malformation Of Lung, Congenital
Most recent studies have shown that Cystic Adenomatoid Malformation Of Lung, Congenital shares some biological mechanisms with bronchopulmonary-sequestration, congenital-abnormality, congenital-bronchogenic-cyst, congenital-diaphragmatic-hernia, congenital-emphysema, diaphragmatic-hernia, edema, fetal-diseases, hernia, hydrops-fetalis, hypoplasia, lung-diseases, lung-neoplasms, neoplasms, pneumonia, polyhydramnios, pulmonary-emphysema, respiratory-distress.
Among the many pathways, these few ones have gauged particular interests from scientists studying Cystic Adenomatoid Malformation Of Lung, Congenital, and have been seen in publications frequently: Cell Adhesion, Cell Cycle, Cell Death, Cell Differentiation, Cell Proliferation, Coagulation, Enucleation, Flight, Localization, Lung Development, Lung Growth, Lung Morphogenesis, Muscle Cell Proliferation, Oncogenesis, Pathogenesis, Programmed Cell Death, Striated Muscle Cell Proliferation, Transport, Vasculogenesis, Vasodilation
Quite a number of genes have been found to play important roles in Cystic Adenomatoid Malformation Of Lung, Congenital, such as AFP, CALM1, CALM2, CALM3, CAMKMT, CAMLG, CHDH, DES, EIF2B5, FGF10, FGF7, HOXB5, KRIT1, MB, MUC2, NKX2-1, NTS, TP53, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.